Advertisement
News
Subscribe to MDT Magazine News

JS Genetics Develops New Non-Invasive Test, XCAT-TS, to Help Doctors Diagnose Turner Syndrome

March 3, 2011 4:36 am | by Bio-Medicine.Org | Comments

NEW HAVEN, Conn., March 3, 2011 /- The launch of a new, non-invasive test for the identification of Turner syndrome (TS) was announced today by JS Genetics.  The test, XCAT-TS, is a simple cheek swab that identifies girls with Turner syndrome. Until now, Turner syndrome could only be...

TOPICS:

Varian Medical Systems to Showcase New X-Ray Tubes and Flat Panel Detectors at the ECR Annual Meeting

March 3, 2011 4:35 am | by Bio-Medicine.Org | Comments

SALT LAKE CITY, March 3, 2011 /- ECR Booth #313/Expo C - Varian Medical Systems, Inc., X-Ray Products, will be showcasing a comprehensive imaging portfolio of PaxScan® digital image detectors and X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging at the...

TOPICS:

Demand pressurises super junction MOSFET producers

March 3, 2011 3:37 am | by I-Micronews | Comments

Super junction MOS FET manufacturers are evolving their strategies after rapid growth in interest in 2010 and with further applications set to take off, Andy Extance finds.

Advertisement

Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech

March 3, 2011 3:35 am | by Boston Scientific | Comments

Company adds innovative technology for atrial fibrillation patients with high stroke risk

TOPICS:

Mitsubishi Electric targets European markets

March 3, 2011 1:37 am | by I-Micronews | Comments

The Japanese conglomerate explains that the German power module manufacturer Vincotech it has acquired is highly complementary to its existing operations, and gives it access to the rapidly growing European photovoltaic market.

Adeona Appoints George J. Brewer, M.D., Senior Vice President of Research & Development

March 3, 2011 1:35 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., March 3, 2011 /- Adeona Pharmaceuticals, Inc. (Amex: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today the appointment of George J. Brewer, M.D., as Senior Vice President of Research & Development.  Dr....

TOPICS:

40% increase in sales for OAI for 2010

March 3, 2011 12:43 am | by I-Micronews | Comments

Fueled by lithography equipment for production.

STATS ChipPAC launches enhanced Flip Chip packaging with fcCuBE? Technology

March 3, 2011 12:42 am | by I-Micronews | Comments

Innovative fcCuBE? delivers a high density, low cost solution with superior reliability for advanced silicon nodes.

Advertisement

FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone

March 2, 2011 9:35 pm | by Bio-Medicine.Org | Comments

SEATTLE, March 3, 2011 /- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that it has met with officials of the FDA's Office of New Drugs ("OND") in Maryland and presented its arguments supporting the Company's belief that the data contained in its New Drug...

TOPICS:

GenMark Diagnostics dismisses patent lawsuit against Caliper Life Sciences, Inc

March 2, 2011 7:38 pm | by I-Micronews | Comments

GenMark Diagnostics Inc. (NASDAQ:GNMK) announced today that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned by Caliper...

Reprogrammed Cells Are Rife with Genetic Mutations

March 2, 2011 7:37 pm | by Massachusetts Institute of Technology | Comments

Before these cells can be used for therapy, scientists need to better understand how reprogramming affects the genome.

Intra-Cellular Therapies and Takeda Enter into Worldwide Collaboration to Develop and Commercialize Compounds for Schizophrenia

March 2, 2011 7:35 pm | by Bio-Medicine.Org | Comments

NEW YORK and OSAKA, Japan, March 2, 2011 /- Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited (TSE: 4502, "Takeda"), today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1)...

TOPICS:

LHC 4Q profit drops with reimbursement cut

March 2, 2011 1:45 pm | by The Associated Press | Comments

Home health provider LHC Group Inc. recorded a 10 percent drop in fourth-quarter profit as the federal government cut Medicare reimbursements, the company reported Wednesday.For the October-through-December period, LHC Group earned $11.4 million, or 63 cents per share, on revenue of $168.1...

Meridian gets new clearance for bacterium test

March 2, 2011 1:45 pm | by The Associated Press | Comments

Meridian Bioscience Inc. said Wednesday that it received clearance for a pediatric claim on its illumigene C. difficile test.The test detects toxigenic strains of C. difficile, a bacterium that can cause diarrhea and colon inflammation. The company said the Food and Drug Administration gave the...

Researchers Predict Age of T Cells to Improve Cancer Treatment

March 2, 2011 12:36 pm | by Georgia Tech Institute of Technology | Comments

Researchers are accurately predicting T cell age and quality in order to improve the effectiveness of the cancer therapy known as adoptive T cell transfer, which is currently limited by the cells' finite lifespan.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading